Xenon Pharmaceuticals Inc (XENE) NPV

Sell:$54.67Buy:$62.00Price decreased$0.40 (0.73%)

NASDAQ:Price decreased2.01%
Market closed |
Prices delayed by at least 15 minutes
Sell:$54.67
Buy:$62.00
Change:Price decreased$0.40 (0.73%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$54.67
Buy:$62.00
Change:Price decreased$0.40 (0.73%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
13 March 2026
Ian Charles MortimerPresident/CEO
Sell
Tax related
7,308$55.23$403,584.3019,923
13 March 2026
Andrea DifabioChief Legal/Compliance Officer
Sell
Tax related
1,342$55.23$74,111.957,301
13 March 2026
Christopher John KenneyOther Level A
Sell
Tax related
1,410$55.23$77,867.257,069
10 March 2026
Ian Charles MortimerPresident/CEO
Sell
Tax related
11,269$60.11$677,357.0514,731
10 March 2026
Andrea DifabioChief Legal/Compliance Officer
Sell
Tax related
2,607$60.11$156,701.564,893
10 March 2026
Christopher John KenneyOther Level A
Sell
Tax related
2,771$60.11$166,559.274,729
9 March 2026
Ian Charles MortimerPresident/CEO
Sell
Option/Award related
43,348$59.26$2,568,802.4872,652
9 March 2026
Ian Charles MortimerPresident/CEO
Sell
Option/Award related
21,791$58.81$1,281,528.7159,209
9 March 2026
Ian Charles MortimerPresident/CEO
Sell
Option/Award related
31,694$59.88$1,897,836.7227,515
9 March 2026
Ian Charles MortimerPresident/CEO
Sell
Option/Award related
12,479$59.50$742,500.5018,521

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
9 March 2026
Ian Charles MortimerPresident/CEO
Sell
Option/Award related
65,000$62.06$4,033,900.006,000
9 March 2026
Ian Charles MortimerPresident/CEO
Sell
Option/Award related
61,652$60.08$3,704,052.166,000
9 March 2026
Ian Charles MortimerPresident/CEO
Sell
Option/Award related
43,348$59.26$2,568,802.4872,652
9 March 2026
Ian Charles MortimerPresident/CEO
Sell
Option/Award related
31,694$59.88$1,897,836.7227,515
2 January 2026
Ian Charles MortimerPresident/CEO
Sell
Option/Award related
37,938$44.40$1,684,447.208,062

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.